Scroll
To Top

May. 24, 2018

TOPIC: Featured News, Press Releases, Research

New Research Funding Opportunities Available from NORD

Posted by Laura Mullen
NORD 2018 Research Grants Available

All U.S. and international researchers are encouraged to apply by the initial application deadline of July 16, 2018

 

Washington, D.C., May 24, 2018 – The National Organization for Rare Disorders (NORD), the leading independent, nonprofit organization committed to the identification, treatment, and cure of rare disorders, announces the availability of new research grants to support the study of eight rare diseases. The initial application deadline is July 16, 2018.

NORD’s Rare Disease Research Grant Program is accepting proposals for the study of:

    • Alveolar Capillary Dysplasia with Misalignment of the Pulmonary Veins (ACD/MPV) – One (1) grant of up to $50,000 U.S. for scientific and/or clinical research studies related to Alveolar Capillary Dysplasia with Misalignment of the Pulmonary Veins (ACD/MPV).
    • Appendix Cancer and Pseudomyxoma Peritonei (PMP) – Two (2) grants of up to $50,000 U.S. for scientific and/or clinical research studies related to Appendix Cancer and/or Pseudomyxoma Peritonei (PMP).
    • Familial Hypercholesterolemia – One (1) grant of up to $50,000 U.S. for scientific and/or clinical research studies related to Familial Hypercholesterolemia.
    • Malonic Aciduria – One (1) grant of up to $80,000 U.S. for scientific and/or clinical research studies related to Familial Hypercholesterolemia.
    • New-Onset Refractory Status Epilepticus (NORSE) and Febrile Infection-Related Epilepsy Syndrome (FIRES) – Grant(s) of up to $100,000 U.S. for scientific research studies related to New-Onset Refractory Status Epilepticus (NORSE) and/or Febrile Infection-Related Epilepsy Syndrome (FIRES).
    • PACS1-Related Syndrome (Schuurs-Hoeijmakers Syndrome) – One (1) grant of up to $45,000 U.S. for scientific and/or clinical research studies related to PACS1-Related Syndrome (Schuurs-Hoeijmakers Syndrome).
    • Primary Orthostatic Tremor – One (1) grant of up to $41,000 U.S. for scientific and/or clinical research studies related to Primary Orthostatic Tremor.

NORD encourages all U.S. and international researchers interested in studying one or more of these diseases to click here to review the full application guidelines detailed in the request for proposals.

NORD’s Rare Disease Research Grant Program provides seed funding to academic scientists for translational or clinical studies related to the development of potential new diagnostics or treatments for rare disease. Over the years, NORD grants have led to the development of two FDA-approved treatments and numerous journal articles. More than 150 grants have been awarded nearing $7 million in approved funding since the program’s launch in 1989.

“We are so thankful for the generous support of our donors year after year,” said Vanessa Boulanger, NORD’s Director of Research Programs. “Community-funded grants play a pivotal role in accelerating foundational and innovative research for rare conditions.  By building strong partnerships within the community and with leading scientific experts, NORD fosters collaboration, so that together, we drive the development of discoveries that save lives.”

Grants are made possible by allies in the rare disease community that have generously donated into NORD’s research fund. Each year, Lundbeck raises awareness and support, in partnership with NORD, through their annual Raise Your Hand Campaign, which runs during the month of February to support Rare Disease Day. We are proud to acknowledge Lundbeck’s charitable donation for NORD’s 2018 Rare Disease Research Grant cycle.

For more information about NORD’s Rare Disease Research Grant Program and rare disease research funding opportunities, visit: http://rarediseases.org/research.

# # #

Leave a Reply

You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>